Showing results (1961-1970 of 3,978) with videos related to

Sort By:
Pageof 398
European Journal of Heart Failure|June 27, 2023
Knowledge about self-efficacy and outcomes in patients with heart failure and reduced ejection fractionMingming Yang, Toru Kondo, Carly Adamson, et al.
European Journal of Heart Failure|June 27, 2023
Global longitudinal strain predicts clinical outcomes in patients with heart failure with preserved ejection fractionAlison Brann, James Miller, Emily Eshraghian, et al.
European Journal of Heart Failure|June 27, 2023
Influenza vaccination and cardiovascular events in patients with ischaemic heart disease and heart failure: A meta-analysisDaniel Modin, Mats Christian Højbjerg Lassen, Brian Claggett, et al.
European Journal of Heart Failure|August 4, 2023
Mineralocorticoid receptor antagonist use and the effects of empagliflozin on clinical outcomes in patients admitted for acute heart failure: Findings from EMPULSEJoão Pedro Ferreira, Jonathan P Blatchford, John R Teerlink, et al.
European Journal of Heart Failure|August 3, 2023
Patient mortality following new-onset heart failure stratified by cancer type and statusNina Nouhravesh, Jarl E Strange, Anders Holt, et al.
European Journal of Heart Failure|July 12, 2023
Improved long-term survival with tafamidis treatment in patients with transthyretin amyloid cardiomyopathy and severe heart failure symptomsPerry Elliott, Balarama Gundapaneni, Marla B Sultan, et al.
European Journal of Heart Failure|July 12, 2023
Foetal recapitulation of nutrient surplus signalling by O-GlcNAcylation and the failing heartMilton Packer
European Journal of Heart Failure|July 5, 2023
Prediction models for heart failure in the community: A systematic review and meta-analysisRamesh Nadarajah, Tanina Younsi, Elizabeth Romer, et al.
European Journal of Heart Failure|July 5, 2023
Similarities and distinctions between acetazolamide and sodium-glucose cotransporter 2 inhibitors in patients with acute heart failure: Key insights into ADVOR and EMPULSEMilton Packer, Javed Butler
European Journal of Heart Failure|June 16, 2023
Eligibility for vericiguat in a real-world heart failure population according to trial, guideline and label criteria: Data from the Swedish Heart Failure RegistryNgoc V Nguyen, Felix Lindberg, Lina Benson, et al.
Pageof 398